About Hangzhou Cancer Hospital
Hangzhou Cancer Hospital is located at the south foot of Wu Hill, a scenic area adjacent to the picturesque West Lake in Hangzhou, China. Operated as a tertiary cancer hospital, Hangzhou Cancer Hospital is a medical center for the prevention and treatment of cancer, integrating clinical care, education, research, prevention activities and public health care. The hospital is a member of the Union for International Cancer Control (UICC) and has been approved as the hospital for the construction of regional tumor centers in north Zhejiang. It operates Zhejiang Regional Centers for Special Diseases and Cancer Center of Hangzhou, and affiliated to the Hangzhou Office of Cancer Prevention, Hangzhou Cancer Research Institute and Hangzhou Quality Control Center for Cancer Diagnosis and Treatment.
Hangzhou Cancer Hospital has 600 operating beds on average. The hospital employs state-of-the-art equipment, including PET-CT scanner (GE, USA), ECT scanner (GE, USA), Axesse and Precise linear accelerator (Elekta, Sweden), Novalis linear accelerator (Varian,USA), large-bore CT stimulator (Philips, USA), all-digital simulator (Nucletron, Netherlands), all-digital large plannar mammography system (Hologic, USA), whole-body hyperthermia system, endogenous field hyperthermia device, and microwave therapeutic instrument.
Hangzhou Cancer Hospital strictly follows the principle of “standard comprehensive treatment and attention to individual differences”, actively promotes standardized multi-disciplinary cancer care including surgery, radiotherapy, chemotherapy, hyperthermia, interventional therapy, biological therapy, traditional Chinese medicine, rehabilitation and etc, and constantly emphasizes the importance of early detection, early diagnosis and early treatment of cancer. The hospital features an outstanding commitment to comprehensive clinical care and complies rigorously with domestic and international guidelines for tumors in all locations and at all stages. We specifically focus on lung cancer, esophageal cancer, nasopharyngeal cancer, brain tumors, thyroid cancer, malignant lymphoma, breast cancer, colorectal cancer, stomach cancer, pancreatic cancer, prostate cancer, cervical cancer, soft tissue sarcoma, malignant melanoma, renal cell carcinoma and other malignancies. We are one of the leading facilities for multimodality treatment of lung cancer, esophageal cancer, nasopharyngeal cancer and thyroid cancer in China, and are renowned for our specialties in combination therapy for bone tumor, gynecologic tumor and liver metastasis and integrative therapy.
Hangzhou Cancer Hospital has more than 700 employees, including a large number of prominent oncologists such as professors Shenglin Ma, Shixiu Wu, Shengyou Lin, Guorong He, Qinghua Deng, and Yuelong Pan and a great many energetic young experts with specialized expertise. The hospital is home to more than 100 staff members with senior titles, 20 with doctoral degrees, and 15 doctoral and master tutors.
The team of distinguished experts appointed by Hangzhou Cancer Hospital is comprised of professor Jinming Yu, an academician of Chinese Academy of Engineering and the founder of tumor precise radiotherapy, several chairmen and committee members of Chinese Medical Association and Chinese Anti-Cancer Association and other esteemed domestic and international experts.
Departments and Centers
Many specialties in Hangzhou Cancer Hospital occupy leading positions in Zhejiang province. The hospital has several provincial and municipal key disciplines such as Cancer Therapy, Cancer Radiation Therapy, Oncology, Integrative Oncology and Experimental Oncology, and operates six municipal medical centers for special diseases including lung cancer, thyroid diseases, breast diseases, lymphoma, pancreatic cancer and liver metastasis.
Hangzhou Cancer Hospital provides advanced clinical care in departments such as surgical oncology, orthopedics & soft tissue neoplasm, gynecologic oncology, and nuclear medicine (municipal PET-CT center) and centers for radiation therapy, chemotherapy, oncology of integrated traditional Chinese and Western medicine , biological therapy, hyperthermia, thyroid disease diagnosis and treatment, breast disease diagnosis and treatment, radiographic and interventional treatment, ultrasound imaging and interventional treatment, children's cancer treatment and etc. Moreover, Hangzhou Cancer Hospital is the first hospital to open Wushan Center for Traditional Chinese Medicine and run a multidisciplinary cooperation ward in Zhejiang province.
Since 2011, Hangzhou Cancer Hospital has maintained its policy of advanced clinical capability, groundbreaking basic research and coordinated development, pursuing a balanced advancement of clinical care, academic activities and scientific productivity. Over the years, we have established Hangzhou Cancer Research Institute, Lung Cancer Research Institute in Zhejiang Academy of Medical Sciences, Zhejiang Provincial Key Laboratory of Molecular Oncology for Integrative Medicine, and Hangzhou Institute for Individualized Medicine. Since 2012, the hospital has been involved in more than 70 longitudinal research projects in various fields, including one 863 subproject and 4 projects supported by National Natural Science Foundation, and one project supported by Provincial Natural Science Foundation； We own more than 10 national patents, have published more than 50 SCI papers and 4 monographs, and have won various awards such as second and third prizes in Provincial Science and Technology Progress Awards, second prize in Science and Technology Progress Award granted by National Education Ministry and first prize in Municipal Science and Technology Progress Award.
Hangzhou Cancer Hospital is the chairmen of the hyperthermia professional committee for the radiotherapy branch of Chinese Medical Association, the radiotherapy and drug professional committees of Zhejiang Anti-Cancer Association, and the oncology branch of Hangzhou Medical Association. The hospital is the deputy heads of the radiotherapy and anti-cancer drug professional committees of Chinese Anti-Cancer Association, the brain metastases professional committee of Chinese Society of Clinical Oncology, the cancer pharmacology and chemotherapy professional committee of Chinese Pharmacological Society, radiotherapy branch of Zhejiang Medical Association, and cancer nutrition and supportive care professional committee of Zhejiang Anti-Cancer Association. The hospital is the deputy presidents of Asian Society of Hyperthermic Oncology, Zhejiang Anti-Cancer Association and Zhejiang Association of Translational Medicine. It is the standing committee member of both the cancer rehabilitation and palliative care professional committee of Chinese Anti-Cancer Association and the geriatric oncology professional committee of Gerontological Society of China.